Modified killer T-cells wipe out leukemia: study
Three US cancer patients were brought back from the brink by a new therapy that turned their own immune cells into tumor killers, wiping out an advanced form of leukemia, researchers said Wednesday.
Cancer
Aug 10, 2011 |
5 / 5 (18) |
3
New gene therapy approach developed for red blood cell disorders
A team of researchers led by scientists at Weill Cornell Medical College has designed what appears to be a powerful gene therapy strategy that can treat both beta-thalassemia disease and sickle cell anemia. They have also ...
Genetics
Mar 27, 2012 |
5 / 5 (5) |
0
|
Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies
A one-dose method for delivering gene therapy into an arterial wall effectively protects the artery from developing atherosclerosis despite ongoing high blood cholesterol. The promising results, published July 19 in the journal ...
Medical research
Jul 19, 2011 |
5 / 5 (3) |
0
|
Manipulation of a specific neural circuit buried in complicated brain networks in primates
A collaborative research team led by Professor Tadashi ISA from The National Institute for Physiological Sciences, The National Institutes of Natural Sciences and Fukushima Medical University and Kyoto University, developed ...
Neuroscience
Jun 17, 2012 |
5 / 5 (3) |
0
Blood groups act as protection against infection
(Medical Xpress)—Humans may have acquired enzymes that make blood groups from bacteria to hinder the spread of viruses in the population, suggests a study led by scientists at the University of Bath.
Medical research
Dec 19, 2012 |
5 / 5 (3) |
0
|
In next-gen DNA sequence, new answers to a rare and devastating disease
In Leigh syndrome, infants are born apparently healthy only to develop movement and breathing disorders that worsen over time, often leading to death by the age of 3. The problem is that the mitochondria responsible for powering ...
Medical research
Sep 06, 2011 |
5 / 5 (2) |
0
|
Leukemia patients remain in remission more than two years after engineered T cell therapy
Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the therapy, which was pioneered by scientists in the ...
Cancer
Dec 10, 2012 |
5 / 5 (2) |
0
Scientists link quickly spreading gene to Asian MRSA epidemic
National Institutes of Health (NIH) scientists and their colleagues in China have described a rapidly emerging Staphylococcus aureus gene, called sasX, which plays a pivotal role in establishing methicillin-resistant S. aureus (MRSA) ...
Genetics
Apr 22, 2012 |
5 / 5 (1) |
0
|
Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Tr ...
HIV & AIDS
May 02, 2012 |
5 / 5 (1) |
0
